MAY-20-13 Dr. Ronald Valdiserri writes to recognize the second anniversary of Combating the
Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care
& Treatment of Viral Hepatitis and to share
an important announcement from Dr. Howard Koh about plans to update and renew the
existing plan through
MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.
|Dr. David Anderson of Tibotec joins Forum EC|
|Dr. David Anderson joins the Forum Executive Committee while holding a position as a US Medical Director in the virology unit of Tibotec Therapeutics. Dr. Anderson currently oversees the NNRTI franchise for Tibotec where, amongst other responsibilities, he represents the US operating company globally and conducts research on currently available and investigational antiretrovirals. His areas of research interest within the field of HIV include investigation of alternative treatment strategies, ARV compartment penetration, and disparities in care within the HIV+ population. Prior to his current role, Dr. Anderson worked as an Associate Medical Director at Gilead Sciences, Inc for several years as his first venture into pharmaceutical industry work. These efforts were preceded by a lengthy period working in practice and research as a principle investigator to serve the needs of patients who were HIV positive. He obtained his MD at the University of California, Los Angeles and completed a residency in Family Medicine and a fellowship in HIV Medicine.|